This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Adverse reactions

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Adverse Reactions to Polio-containing vaccine

Confirmed anaphylaxis occurs extremely rarely. Data from the UK, Canada and the US point to rates of 0.65 to 3 anaphylaxis events per million doses of vaccine given (1)

severe or mild systemic or local reaction within 72 hours of receiving a preceding vaccine. Immunisation with IPV-containing vaccine should continue following a history of (1):

  • fever, irrespective of its severity
  • hypotonic-hyporesponsive episodes (HHE)
  • persistent crying or screaming for more than three hours
  • severe local reaction, irrespective of extent

A previous version of the Green Book noted (2):

  • pain, swelling or redness at the injection site are common and may occur more frequently following subsequent doses
    • a small, painless nodule may form at the injection site; this usually disappears and is of no consequence
    • incidence of local reactions is lower with tetanus vaccines combined with acellular pertussis vaccines, than with whole-cell pertussis vaccines and similar to that after DT vaccine

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 26 Poliomyelitis (April 2019).
  2. Immunisation Against Infectious Disease - "The Green Book".Chapter 26 Poliomyelitis (August 2006).

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.